SRDX
Surmodics, Inc. (SRDX) SWOT Analysis Analysis (2026)
Overall Score
Strengths
Strong liquidity with a current ratio of 3.9x and quick ratio of 3.1x.
Gross margin remains high at 71.5%, supporting underlying product economics.
Balance sheet leverage is modest, with debt-to-equity at 0.29x and debt-to-assets at 0.19x.
Weaknesses
Profitability remains negative, with net margin at -18.3% and operating margin at -16.0%.
Cash generation is weak relative to valuation, with free cash flow yield at just 0.25% and price-to-free-cash-flow above 400x.
Working capital efficiency is poor, with a cash conversion cycle of 377 days driven by 158 days of receivables and 351 days of inventory outstanding.
Opportunities
If revenue scales, the company could leverage its 71.5% gross margin into better operating leverage.
The strong current ratio provides flexibility to fund operations and growth without near-term liquidity pressure.
Net current asset value remains positive at $17.5M, offering some downside support.
Threats
Persistent losses and negative returns on assets, equity, and invested capital indicate ongoing execution risk.
Valuation remains demanding at 10.7x sales and 400.6x free cash flow despite negative earnings.
High inventory and receivables levels increase the risk of further cash flow strain if demand softens or collections slow.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Surmodics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

